Cargando…
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer
IMPORTANCE: Triplet chemotherapy with fluorouracil, folinic acid, oxaliplatin, and irinotecan plus bevacizumab (FOLFOXIRI-B) is an effective first-line treatment option for patients with metastatic colorectal cancer (mCRC). However, the degree of implementation of FOLFOXIRI-B in daily practice is un...
Autores principales: | van Nassau, Sietske C., Bond, Marinde J., Scheerman, Ilva, van Breeschoten, Jesper, Kessels, Rob, Valkenburg-van Iersel, Liselot B., Verheul, Henk M., Buffart, Tineke E., Mekenkamp, Leonie J., Lemmens, Valery E., Koopman, Miriam, Bol, Guus M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433607/ https://www.ncbi.nlm.nih.gov/pubmed/34505885 http://dx.doi.org/10.1001/jamanetworkopen.2021.24766 |
Ejemplares similares
-
Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands
por: Oelen, Yrina, et al.
Publicado: (2022) -
ShrinkBayes: a versatile R-package for analysis of count-based sequencing data in complex study designs
por: van de Wiel, Mark A, et al.
Publicado: (2014) -
Signet Ring Cell Carcinoma of the Ampulla of Vater: A Rare Histopathological Variant
por: de Klein, Guus W., et al.
Publicado: (2018) -
Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer
por: Poel, Dennis, et al.
Publicado: (2018) -
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors
por: Någård, Mats, et al.
Publicado: (2020)